These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 3509341)

  • 1. Enhanced percutaneous absorption of homogenized tolnaftate/beta-cyclodextrin polymer ground mixture.
    Szeman J; Ueda H; Szejtli J; Fenyvesi E; Watanabe Y; Machida Y; Nagai T
    Drug Des Deliv; 1987 May; 1(4):325-32. PubMed ID: 3509341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin.
    Ventura CA; Tommasini S; Falcone A; Giannone I; Paolino D; Sdrafkakis V; Mondello MR; Puglisi G
    Int J Pharm; 2006 May; 314(1):37-45. PubMed ID: 16581211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies.
    Szente L; Apostol I; Gerlóczy A; Szejtli J
    Pharmazie; 1985 Jun; 40(6):406-7. PubMed ID: 4034649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.
    Faucci MT; Mura P
    Drug Dev Ind Pharm; 2001 Oct; 27(9):909-17. PubMed ID: 11763468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
    Wang L; Jiang X; Xu W; Li C
    Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin.
    Sridevi S; Chauhan AS; Chalasani KB; Jain AK; Diwan PV
    Pharmazie; 2003 Nov; 58(11):807-10. PubMed ID: 14664337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
    Fathy M; Sheha M
    Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of dissolution and absorption characteristics of indomethacin by water-soluble alpha-cyclodextrin-epichlorohydrin polymer.
    Uekama K; Udo K; Irie T; Yoshida A; Otagiri M; Seo H; Tsuruoka M
    Acta Pharm Suec; 1987; 24(1):27-36. PubMed ID: 3618246
    [No Abstract]   [Full Text] [Related]  

  • 11. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion complex of trimethoprim with beta-cyclodextrin.
    Li N; Zhang YH; Wu YN; Xiong XL; Zhang YH
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):824-9. PubMed ID: 16011886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL; Pore YV; Kuchekar BS; Late SG
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of pharmacological activity of CERM 3726 with a ground mixture of beta-cyclodextrin in mice.
    Luu SN; Chaperon F; Leinot M; Pourrat A
    Pharm Acta Helv; 1987; 62(12):335-6. PubMed ID: 3441478
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancing effect of absorption promoters on percutaneous absorption of a model dye (6-carboxyfluorescein) as poorly absorbable drugs. II. Study on the absorption promoting effect of azone.
    Ohshima T; Yoshikawa H; Takada K; Muranishi S
    J Pharmacobiodyn; 1985 Nov; 8(11):900-5. PubMed ID: 4093845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel spectral manipulations for determinations of Tolnaftate along with related toxic compounds: Drug profiling and a comparative study.
    Emam RA; Abdelrahman MM; Abdelaleem EA; Ali NW
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Dec; 223():117290. PubMed ID: 31284238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External application of hsiao chung ting t'ung san in treatment of injury.
    YEH CY
    Zhonghua Wai Ke Za Zhi; 1960 Feb; 8():187-8. PubMed ID: 13855449
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences with chlorisept in the treatment of mycotic diseases of the skin].
    SCHULZ HJ
    Z Haut Geschlechtskr; 1950 Dec; 9(11):470-2. PubMed ID: 14810083
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of vehicles on percutaneous absorption. III. Simulation and measurement of input data.
    Takehara M; Nakagawa T; Ushio Y; Narahara K; Oishi H
    Chem Pharm Bull (Tokyo); 1976 Aug; 24(8):1779-83. PubMed ID: 975434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.